Skip to main content
CALC logo

CALC

CalciMedica, Inc.

$0.95

5.54%

Trade Ideas Performance

Latest Closed Trade Idea

$0.95

5.54%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

2

Social

21

About

Events of CalciMedica, Inc. (CALC)

CalciMedica's stock price was significantly impacted by the discontinuation of the Phase 2 KOURAGE trial for Auxora in AKI due to safety concerns, leading to a substantial drop in stock value. The company reported 2025 financial results and clinical updates in March 2026, confirming no drug-related toxicity with Auxora and discussing future clinical studies with the FDA. CalciMedica received Nasdaq deficiency notices and its stock price has decreased by 90.5% since the start of the year.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
CalciMedica, Inc. (CALC) Live Stock Price, Chart & Financial News | Edge Hound